Isn't it amazing that sepsis, hemorrhaging, renal figure, lung failure, heart problems, bone marrow failure and liver injury -- bringing on the deaths of 7 percent of the patients -- can be ignored, while Leronlimab has been stuck on a "safety" hold despite an almost-perfect safety record with over a thousand patients -- a "safety" hold that includes months of dickering with a clinical protocol?

Gotta say that my investment in CYDY has changed my attitude about the FDA from occasional doubt to overweening contempt. In matters of life and death, they are literally on the wrong side.